32 Biosciences Three Squared

32 Biosciences is a biotechnology company focused on gastrointestinal (GI) diseases initially centered on the colon, addressing high unmet medical needs in prevention and treatment with a first-in-class therapeutic and a novel discovery platform. A compromised gastrointestinal mucosal barrier is linked to infection risk, chronic disease, and microbiome imbalance. Our pipeline of GI indications entails $100B+ of US health system costs. To prevent and treat disease, we are restoring and protecting the GI mucosal-immune system while building a proprietary GI discovery platform.